ResolveMDx

About MDxHealth

MDxHealth is a Nasdaq-listed precision diagnostics company dedicated to personalizing urologic care, primarily in prostate cancer. Its strategy centers on commercializing and expanding a menu of proprietary, non-invasive and tissue-based molecular tests, such as ConfirmMDx, GPS, SelectMDx, and ExoDx, which are supported by extensive clinical validation. The company aims to grow by increasing test adoption, securing favorable payer reimbursement, and leveraging its commercial infrastructure to enhance patient access and clinical utility.

Therapeutic Areas